Bausch Health Companies Inc. BHC.TO

BHC.TO Company Overview

Bausch Health Companies Inc. is a global pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription drugs, over-the-counter products, and medical devices. The company operates primarily in the pharmaceuticals and medical aesthetics industries, serving healthcare providers, hospitals, pharmacies, and patients across multiple therapeutic areas. Its revenue is driven mainly by branded prescription products, with additional contributions from consumer health products and ophthalmology devices.

The company’s core portfolio spans gastroenterology, ophthalmology, dermatology, neurology, and aesthetics, with several established brands generating recurring revenue. Bausch Health is positioned as a diversified specialty pharmaceutical company with strong brand recognition in niche therapeutic categories. Originally founded in 1833 as Bausch & Lomb, the company evolved through decades of expansion and acquisitions, later operating as Valeant Pharmaceuticals before rebranding as Bausch Health Companies Inc. in 2018 to reflect a renewed strategic focus on sustainable growth, compliance, and operational discipline.